PMID- 29391899 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200929 IS - 1792-1074 (Print) IS - 1792-1082 (Electronic) IS - 1792-1074 (Linking) VI - 15 IP - 1 DP - 2018 Jan TI - CoCl(2) increases the expression of hypoxic markers HIF-1alpha, VEGF and CXCR4 in breast cancer MCF-7 cells. PG - 1119-1124 LID - 10.3892/ol.2017.7369 [doi] AB - The aim of the present study was to investigate the effect of a hypoxic environment on the biological behavior of breast cancer MCF-7 cells, using CoCl(2) to mimic the hypoxia model in breast cancer cells. Using 50, 100, 150 and 200 microM CoCl(2) as a hypoxic inducer, a hypoxic model was established in MCF-7 cells in vitro. MTT, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) and western blotting assays were performed to detect MCF-7 cell proliferation under hypoxic conditions and the expression of the hypoxic markers hypoxia-inducible factor-1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF) and C-X-C motif chemokine receptor 4 (CXCR4) mRNA and that of the associated proteins. The RT-qPCR results revealed that there were no obvious changes in the expression of HIF-1alpha mRNA; however, the expression of CXCR4 and VEGF mRNA increased significantly following treatment with different CoCl(2) concentrations (P<0.05). The results of western blotting identified that CoCl(2) significantly induced the expression of HIF-1alpha, CXCR4 and VEGF proteins (P<0.05). The MTT assay revealed that different concentrations of CoCl(2) inhibited the proliferation of MCF-7 cells. The TUNEL assay demonstrated that CoCl(2) was able to trigger apoptosis of MCF-7 cells. Therefore, the results of the present study identified that CoCl(2) is able to control MCF-7 cell proliferation and apoptosis, also increasing the expression of HIF-1alpha, CXCR4 and VEGF. The present study may aid the discovery of a novel method to prevent cell damage and decrease cell proliferation in order to prevent the occurrence and development of breast cancer. FAU - Li, Qing AU - Li Q AD - Department of Breast and Thyroid Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250000, P.R. China. FAU - Ma, Rong AU - Ma R AD - Department of Breast and Thyroid Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250000, P.R. China. FAU - Zhang, Mei AU - Zhang M AD - Department of Breast and Thyroid Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250000, P.R. China. LA - eng PT - Journal Article DEP - 20171108 PL - Greece TA - Oncol Lett JT - Oncology letters JID - 101531236 PMC - PMC5769392 OTO - NOTNLM OT - C-X-C motif chemokine receptor 4 OT - CoCl2 OT - MCF-7 cell OT - breast cancer OT - cell proliferation OT - hypoxia model OT - hypoxia-inducible factor-1alpha OT - vascular endothelial growth factor EDAT- 2018/02/03 06:00 MHDA- 2018/02/03 06:01 PMCR- 2017/11/08 CRDT- 2018/02/03 06:00 PHST- 2016/08/12 00:00 [received] PHST- 2017/09/13 00:00 [accepted] PHST- 2018/02/03 06:00 [entrez] PHST- 2018/02/03 06:00 [pubmed] PHST- 2018/02/03 06:01 [medline] PHST- 2017/11/08 00:00 [pmc-release] AID - OL-0-0-7369 [pii] AID - 10.3892/ol.2017.7369 [doi] PST - ppublish SO - Oncol Lett. 2018 Jan;15(1):1119-1124. doi: 10.3892/ol.2017.7369. Epub 2017 Nov 8.